Notch-2

Results: 33



#Item
121st International Conference on Composite Materials Xi’an, 20-25th August 2017 A STUDY ON FIBER-ARRANGEMENT CLOSE TO THE ROOT OF A SHARP NOTCH, FOR SHORT FIBER-REINFORCED THERMOPLASTICS R. Pietrogrande1,2,*, M. De Mon

21st International Conference on Composite Materials Xi’an, 20-25th August 2017 A STUDY ON FIBER-ARRANGEMENT CLOSE TO THE ROOT OF A SHARP NOTCH, FOR SHORT FIBER-REINFORCED THERMOPLASTICS R. Pietrogrande1,2,*, M. De Mon

Add to Reading List

Source URL: www.iccm-central.org

Language: English - Date: 2017-12-26 22:47:23
    2AERIAL LIDAR ACQUISITION REPORT __________________ TUG NOTCH LIDAR *.LAS1.2 DATA COMPREHENSIVE AND BARE EARTH

    AERIAL LIDAR ACQUISITION REPORT __________________ TUG NOTCH LIDAR *.LAS1.2 DATA COMPREHENSIVE AND BARE EARTH

    Add to Reading List

    Source URL: tagis.dep.wv.gov

    Language: English - Date: 2013-06-27 14:36:32
      3

      -76200039052500AERIAL LIDAR ACQUISITION REPORT __________________ TUG NOTCH LIDAR *.LAS1.2 DATA COMPREHENSIVE AND BARE EARTH

      Add to Reading List

      Source URL: tagis.dep.wv.gov

      Language: English - Date: 2013-06-26 17:37:55
        4

        -76200039052500AERIAL LIDAR ACQUISITION REPORT __________________ TUG NOTCH LIDAR *.LAS1.2 DATA COMPREHENSIVE AND BARE EARTH

        Add to Reading List

        Source URL: tagis.dep.wv.gov

        Language: English - Date: 2013-06-26 17:37:55
          5NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

          NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

          Add to Reading List

          Source URL: posters.omed.s3.amazonaws.com

          - Date: 2015-12-11 14:21:05
            6Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

            Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

            Add to Reading List

            Source URL: s3.amazonaws.com

            - Date: 2014-09-25 16:16:58
              7NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

              NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

              Add to Reading List

              Source URL: posters.omed.s3.amazonaws.com

              - Date: 2016-02-21 23:46:50
                8Updated Results of Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch 2/3) in Combination with Etoposide and Platinum Therapy (EP) in Patients (pts) with Untreated Extensive-Stage Small Cell Lung Cancer (ED-SCLC) Copies

                Updated Results of Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch 2/3) in Combination with Etoposide and Platinum Therapy (EP) in Patients (pts) with Untreated Extensive-Stage Small Cell Lung Cancer (ED-SCLC) Copies

                Add to Reading List

                Source URL: s3.amazonaws.com

                Language: English - Date: 2016-06-04 05:53:42
                9Valentine day _20140112 - 2

                Valentine day _20140112 - 2

                Add to Reading List

                Source URL: review.ifom.eu

                Language: English - Date: 2014-11-05 05:40:22
                10Top Notch Beef Served with your choice of side listed below (add 2.00 for broccoli rabe side) BEAT THE CLOCK

                Top Notch Beef Served with your choice of side listed below (add 2.00 for broccoli rabe side) BEAT THE CLOCK

                Add to Reading List

                Source URL: vallecucina.com

                Language: English - Date: 2015-12-16 18:50:16